Protein tyrosine kinase inhibitor compounds are described, as are methods for their preparation, pharmaceutical compositions including such compounds, and their use in medicine, for example in the treatment of cancer and psoriasis. In particular, the use of an inhibitor of both EGFR and erbB-2 in the treatment of a susceptible malignancy, such as cancer or a malignant tumour, is described.
本文描述了
蛋白酪氨酸激酶抑制剂化合物、其制备方法、包括此类化合物的药物组合物及其在医学中的用途,例如在治疗癌症和牛皮癣中的用途。特别介绍了
表皮生长因子受体和erbB-2
抑制剂在治疗易感恶性肿瘤(如癌症或恶性肿瘤)中的应用。